Skip to main content
TipRanks
Go Ultimate75% OFF

Vicore Pharma Holding AB (VICO) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Vicore Pharma Holding AB has a market cap or net worth of SEK 3.02B. The enterprise value is SEK 1.93B.

Market Cap
SEK 3.02B
Enterprise Value
SEK 1.93B

Share Statistics

Vicore Pharma Holding AB has 281,644,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
281,644,500
Owned by Insiders
―
Owned by Institutions
6.02%

Financial Efficiency

Vicore Pharma Holding AB’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -41.20%.

Return on Equity (ROE)
-0.44
Return on Assets (ROA)
-0.39
Return on Invested Capital (ROIC)
-41.20%
Return on Capital Employed (ROCE)
-0.41
Revenue Per Employee
82.98K
Profits Per Employee
-10.38M
Employee Count
46
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Vicore Pharma Holding AB is -5.65. Vicore Pharma Holding AB’s PEG ratio is -0.36.

PE Ratio
-5.65
PS Ratio
781.36
PB Ratio
4.14
Price to FCF
-8.89
Price to Operating Cash Flow
-6.09
PEG Ratio
-0.36

Income Statement

In the last 12 months, Vicore Pharma Holding AB had revenue of 3.82M and earned -477.47M in profits. Earnings per share was -1.99.

Revenue
3.82M
Gross Profit
3.82M
Operating Income
-454.44M
Pretax Income
-477.47M
Net Income
-477.47M
EBITDA
-477.41M
Earnings Per Share (EPS)
-1.99

Cash Flow

In the last 12 months, operating cash flow was -492.50M and capital expenditures 355.04M, giving a free cash flow of -336.58M billion.

Operating Cash Flow
-492.50M
Free Cash Flow
-336.58M
Free Cash Flow per Share
-1.19

Dividends & Yields

Vicore Pharma Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-11.25%
Earnings Yield
-17.10%

Stock Price Statistics

Beta
0.75
52-Week Price Change
6.63%
50-Day Moving Average
9.77
200-Day Moving Average
10.61
Relative Strength Index (RSI)
61.47
Average Volume (3m)
1.18M

Important Dates

Vicore Pharma Holding AB upcoming earnings date is Feb 25, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Vicore Pharma Holding AB as a current ratio of 10.31, with Debt / Equity ratio of 0.00%

Current Ratio
10.31
Quick Ratio
10.31
Debt to Market Cap
0.00
Net Debt to EBITDA
1.21
Interest Coverage Ratio
-9.03

Taxes

In the past 12 months, Vicore Pharma Holding AB has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Vicore Pharma Holding AB EV to EBITDA ratio is -4.59, with an EV/FCF ratio of -7.71.

EV to Sales
677.95
EV to EBITDA
-4.59
EV to Free Cash Flow
-7.71
EV to Operating Cash Flow
-5.27

Balance Sheet

Vicore Pharma Holding AB has SEK 771.99M in cash and marketable securities with SEK 0.00 in debt, giving a net cash position of SEK 771.99M billion.

Cash & Marketable Securities
SEK 771.99M
Total Debt
SEK 0.00
Net Cash
SEK 771.99M
Net Cash Per Share
SEK 2.74
Tangible Book Value Per Share
SEK 2.57

Margins

Gross margin is 100.00%, with operating margin of -14161.60%, and net profit margin of -13397.10%.

Gross Margin
100.00%
Operating Margin
-14161.60%
Pretax Margin
-13390.33%
Net Profit Margin
-13397.10%
EBITDA Margin
-14756.35%
EBIT Margin
-14756.35%

Analyst Forecast

The average price target for Vicore Pharma Holding AB is SEK 39.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
SEK 39.00
Price Target Upside
267.23% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
-54.97%
EPS Growth Forecast
-1.66%

Scores

Smart Score
―
AI Score
53